Herrera-Espejo, Soraya , Fontsere, Sara , Infante, Carmen , Suarez-Benjumea, Alejandro , Carretero-Ledesma, Marta , Suner-Poblet, Marta , Gonzalez-Corvillo, Carmen , Bernal, Gabriel , MARTÍN GUTIÉRREZ, GUILLERMO, Perez-Caceres, Juan Antonio , Pachon, Jeronimo , Pachon-Ibanez, Maria Eugenia , Cordero, Elisa
No
Antibiotics (Basel)
Article
Científica
01/02/2024
001175087400001
Different factors, including antimicrobial resistance, may diminish the effectiveness of antibiotic therapy, challenging the management of post-transplant urinary tract infection (UTI). The association of acidic urine pH with microbiological and clinical outcomes was evaluated after fosfomycin or ciprofloxacin therapy in 184 kidney transplant recipients (KTRs) with UTI episodes by Escherichia coli (N = 115) and Klebsiella pneumoniae (N = 69). Initial urine pH, antimicrobial therapy, and clinical and microbiological outcomes, and one- and six-month follow-up were assessed. Fosfomycin was prescribed in 88 (76.5%) E. coli and 46 (66.7%) K. pneumoniae UTI episodes in the total cohort. When the urine pH <= 6, fosfomycin was prescribed in 60 (52.2%) E. coli and 29 (42.0%) K. pneumoniae. Initial urine pH <= 6 in E. coli UTI was associated with symptomatic episodes (8/60 vs. 0/55, p = 0.04) at one-month follow-up, with a similar trend in those patients receiving fosfomycin (7/47 vs. 0/41, p = 0.09). Acidic urine pH was not associated with microbiological or clinical cure in K. pneumoniae UTI. At pH 5, the ciprofloxacin MIC90 increased from 8 to >8 mg/L in E. coli and from 4 to >8 mg/L in K. pneumoniae. At pH 5, the fosfomycin MIC90 decreased from 8 to 4 mg/L in E. coli and from 512 to 128 mg/L in K. pneumoniae. Acidic urine is not associated with the microbiological efficacy of fosfomycin and ciprofloxacin in KTRs with UTI, but it is associated with symptomatic UTI episodes at one-month follow-up in E. coli episodes.
urinary tract infections; urine pH; ciprofloxacin; fosfomycin; kidney transplant recipients; Escherichia coli; Klebsiella pneumoniae